Transdermal oxybutynin in the treatment of overactive bladder

Overactive bladder is a dreadful syndrome that affects a considerable number of patients. Antimuscarinics are the mainstay of pharmacotherapy for this condition. Transdermal (TD) oxybutynin (OXY) bypasses the first-pass metabolism and reduces the formation of N-desethyloxybutynin, a compound believe...

Descripción completa

Detalles Bibliográficos
Autor principal: Davila, G Willy
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2006
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695169/
https://www.ncbi.nlm.nih.gov/pubmed/18044106

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2695169/
https://www.ncbi.nlm.nih.gov/pubmed/18044106

Ejemplares similares